Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Camp4 Therapeutics Corp (CAMP)

Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Camp4 Therapeutics Corp ONE KENDALL SQUARE BUILDING 1400 WEST 3RD FLOOR CAMBRIDGE MA 02139 USA

www.camp4tx.com Employees: 58 P: 617-651-8867

Description:

CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases. CAMP4 Therapeutics Corporation is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 103,962
Enterprise Value, $K 103,962
Shares Outstanding, K 19,505
Annual Sales, $ 294,950 K
Annual Net Income, $ -32,490 K
Last Quarter Sales, $ 53,625 K
Last Quarter Net Income, $ -85,004 K
EBIT, $ 0 K
EBITDA, $ 0 K
% of Insider Shareholders 1.27%
% of Institutional Shareholders 0.00%
Float, K 19,257
% Float 98.73%
Short Volume Ratio 0.71

Growth:

1-Year Return -46.08%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/08/24
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 188.30%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CAMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -11.02%
Debt/Equity 0.00
Price/Sales 297.04
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar